Global Hematopoietic Stem Cell Transplantation (HSCT) Market to surpass US$ 4,391.0 million by 2027, Says Coherent Market Insights (CMI)

SEATTLE–(BUSINESS WIRE)–#BoneMarrowTransplant–According to Coherent Market Insights, the global hematopoietic stem cell transplantation market is estimated to be valued at US$ 2,092.6 million in 2020 and is expected to exhibit a CAGR of 11.2% during the forecast period (2020-2027).

Key Trends and Analysis:

The global hematopoietic stem cell transplantation market is expected to witness significant growth owing to increasing research and development of novel therapies. For instance, in October 2017, the University of California, San Francisco, U.S. initiated clinical phase I study to evaluate the safety and efficacy of ‘In Utero Hematopoietic Stem Cell Transplantation’ for treatment of fetuses with alpha thalassemia major. This is a blood disorder which reduces production of hemoglobin. The study is expected to complete in February 2024.

Increasing research and patent filings by market players is expected to propel the market growth. For instance, in 2017, VistaGen Therapeutics Inc. announced the issuance of U.S. Patent No. 9,834,754 by the U.S. Patent and Trademark Office (USPTO) on the methods for producing human pluripotent stem cells (hPSCs), hematopoietic precursor stem cells which can aid treatment of autoimmune disorders and cancer.

Furthermore, the increasing prevalence of myeloid leukemia is expected to create a conducive environment for market growth. The American Cancer Society had estimated around 21,380 new cases of acute myeloid leukemia (AML) and 10,590 deaths from AML in the U.S., in 2016.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1250

Key Market Takeaways:

The global hematopoietic stem cell transplantation market is expected to exhibit A CAGR of 11.2% during the forecast period (2020-2027) owing to the increasing prevalence of Hodgkin lymphoma in the U.S. For instance, according to the National Cancer Institute, in 2017, around 215,531 people were living with Hodgkin lymphoma in the U.S.

North America is expected to be the most lucrative region in the hematopoietic stem cell transplantation market due to rise in the number of hematopoietic cell transplants.

Competitive Landscape:

Key players operating in the global hematopoietic stem cell transplantation market are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Talaris Therapeutics, Inc., Marker Therapeutics Inc., and Stempeutics Research Pvt Ltd.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/1250

Market Segmentation:

• Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Transplant Type:
  • Allogeneic
  • Autologous
• Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Indication:
  • Acute Myeloid Leukemia (AML)
  • Acute Lymphoblastic Leukemia (ALL)
  • Hodgkin lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)
  • Multiple Myeloma (MM)
  • Other Non-Malignant Disorders
• Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Application:
  • Bone Marrow Transplant (BMT)
  • Peripheral Blood Stem Cells Transplant (PBSCT)
  • Cord Blood Transplant (CBT)
• Global Hematopoietic Stem Cell Transplantation (HSCT) Market, By Region:
  • North America
    • By Country:
      • U.S.
      • Canada
  • Europe
    • By Country:
      • U.K.
      • Germany
      • Italy
      • Spain
      • France
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country:
      • Australia
      • India
      • China
      • Japan
      • ASEAN
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • By Country:
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Country/Region:
      • South Africa
      • Central Africa
      • North Africa

Related Market Intelligence Reports:

Stem Cells Market, By Type (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Natural Rosette Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery and Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) – Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/stem-cells-market-4222

Stem Cell Cartilage Regeneration Market, by Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), by Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), by End User (Hospitals & Clinics and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/stem-cell-cartilage-regeneration-market-2448

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.

Contacts

Mr. Shah

Senior Client Partner – Business Development

Coherent Market Insights

Phone:
US: +1-206-701-6702

UK: +44-020-8133-4027

Japan: +81-050-5539-1737

India: +91-848-285-0837

Email: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow Us: LinkedIn | Twitter